TWiV 719: COVID-19 clinical update #49 with Dr. Daniel Griffin
Feb 13, 2021•28 min•Ep. 719
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #49, Daniel Griffin discusses CDC guidelines on mask use, drop in test frequency in the US, resurgence of COVID-19 in Brazil, possible impact of Pfizer vaccine on viral load, EUA for bamlanivimab and etesevimab administered together, and preliminary results of Tocilizumab in hospitalized patients.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Resurgence of COVID-19 in Brazil (Lancet)
- Pfizer vaccine reduces viral load (medRxiv)
- EUA for bamlanivimab plus etesevimab (pdf)
- Tocilizumab in hospitalized patients (medRxiv)
- Bacterial superinfections in COVID-19 (Open For Inf Dis)
- Letters read on TWiV 719
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android